ID: ALA510590

Max Phase: Preclinical

Molecular Formula: C4H8ClN3O2

Molecular Weight: 129.12

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CNCc1nnc(O)o1.Cl

Standard InChI:  InChI=1S/C4H7N3O2.ClH/c1-5-2-3-6-7-4(8)9-3;/h5H,2H2,1H3,(H,7,8);1H

Standard InChI Key:  CCVASKUEYWRHFV-UHFFFAOYSA-N

Associated Targets(non-human)

GABA receptor alpha-6 subunit 76 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 129.12Molecular Weight (Monoisotopic): 129.0538AlogP: -0.51#Rotatable Bonds: 2
Polar Surface Area: 71.18Molecular Species: ACIDHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 1.73CX Basic pKa: 6.95CX LogP: -1.87CX LogD: -2.35
Aromatic Rings: 1Heavy Atoms: 9QED Weighted: 0.56Np Likeness Score: -0.83

References

1. Jansen M, Rabe H, Strehle A, Dieler S, Debus F, Dannhardt G, Akabas MH, Lüddens H..  (2008)  Synthesis of GABAA receptor agonists and evaluation of their alpha-subunit selectivity and orientation in the GABA binding site.,  51  (15): [PMID:18651727] [10.1021/jm701562x]

Source